Price alert —
Sign in to get a one-time email the moment NVO crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · NVO
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96.8B | $48.6B | $59.6B | $12.0B | 50.2% | 61.6% |
| 2025-12-31 | $79.1B | $26.9B | $31.7B | $-36.2B | 34.0% | 40.1% |
| 2025-09-30 | $75.0B | $20.0B | $23.7B | $30.7B | 26.7% | 31.6% |
| 2025-06-30 | $76.9B | $26.5B | $33.4B | $24.4B | 34.5% | 43.5% |
| 2025-03-31 | $78.1B | $29.0B | $38.8B | $10.1B | 37.2% | 49.7% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare NVO vs peers
Line NVO up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
NVO
NVO
$50.32
-2.25%
JNJ
Johnson & Johnson
$253.04
+1.23%
AMZN
Amazon.com, Inc.
$247.23
-1.06%
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-05 | 6.63 | 6.96 | -4.8% | +2.0% |
| 2026-02-03 | 6.04 | 5.90 | +2.3% | -6.2% |
| 2025-11-05 | 4.50 | 4.24 | +6.0% | -4.0% |
| 2025-08-06 | 5.96 | 6.00 | -0.7% | +7.5% |
| 2025-05-07 | 6.53 | 6.07 | +7.5% | -4.0% |
| 2025-02-04 | 6.34 | 5.97 | +6.2% | +3.8% |
| 2024-11-06 | 6.12 | 5.92 | +3.4% | +2.1% |
| 2024-08-07 | 4.49 | 4.91 | -8.6% | +7.5% |
| 2024-05-02 | 5.68 | 5.42 | +4.9% | -0.8% |
| 2024-01-31 | 4.91 | 4.45 | +10.3% | +0.9% |
| 2023-11-02 | 5.00 | 4.71 | +6.2% | -2.7% |
| 2023-08-09 | 4.32 | 4.50 | -4.0% | -2.9% |
| 2023-05-04 | 4.39 | 4.02 | +9.1% | +1.8% |
| 2023-02-01 | 3.01 | 3.13 | -3.8% | -4.8% |
| 2022-11-02 | 3.17 | 3.12 | +1.7% | +0.6% |
| 2022-08-03 | 2.93 | 3.03 | -3.4% | +4.6% |
| 2022-04-29 | 3.11 | 2.89 | +7.5% | -0.1% |
| 2022-02-01 | 2.38 | 2.36 | +1.0% | +3.9% |
| 2021-11-03 | 2.64 | 2.55 | +3.2% | +0.2% |
| 2021-08-04 | 2.63 | 2.38 | +10.4% | +5.0% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| NVO ★ | $223B | 12.1 | 14.9 | 0.7 | 2.0 | 7.2 | 83.2% | 24.0% | 67.1% | -5.41% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 3.73%
| Holder | Shares | % out |
|---|---|---|
| Dodge & Cox Inc. | 19,333,750 | 0.57% |
| LOOMIS SAYLES & CO L P | 17,017,315 | 0.50% |
| Franklin Resources, Inc. | 16,083,479 | 0.47% |
| Capital International Investors | 11,795,850 | 0.35% |
| Susquehanna International Group, LLP | 11,106,111 | 0.33% |
| Price (T.Rowe) Associates Inc | 11,060,680 | 0.33% |
| Morgan Stanley | 10,869,200 | 0.32% |
| Bank of America Corporation | 10,769,699 | 0.32% |
| Fisher Asset Management, LLC | 9,021,103 | 0.27% |
| Folketrygdfondet | 9,080,820 | 0.27% |
Insider activity · 90d
No insider trades for NVO in last 90d.
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
No filings available.
About NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Options picks · NVO
ITM + OTM ideas from the latest scanLoading…
Congress trades · NVO
STOCK Act disclosuresLoading…
SEC filings & insiders · NVO
EDGAR · liveLoading…
Holders · NVO
Institutions & insider activityLoading…